Surgeon General report on mefloquine: D2-526/2017E-PDF

“The Canadian Armed Forces (CAF) approach to malaria prevention, including use of malaria medication (called malaria chemoprophylaxis (MCP)), is consistent with the Canadian clinical practice guidelines (CPG) on malaria prevention and treatment. In most areas where the most dangerous form of malaria occurs (Plasmodium falciparum), the Canadian CPG and the CAF recommend that travelers use one of three options for MCP: mefloquine, atovaquone-proguanil (AP) (brand name Malarone), or doxycycline. Within the CAF and with respect to these options, the current policy is that the individual member, after suitable discussion with their health care provider, can choose his/her preferred agent from among those that are deemed medically suitable. The continued use of mefloquine as a MCP option in the CAF has recently received significant scrutiny. Given the concerns that have been raised about mefloquine, the Canadian Armed Forces Chief of Defence Staff (CDS) instructed the Surgeon General (SG) to critically analyze the body of knowledge regarding mefloquine, and to undertake a review of the CAF experience with the medication. This report is the SG response to this tasking"--Introd., p. 1, 2.

Permanent link to this Catalogue Record: What is a permanent link?
MARC XML Format   MARC HTML Format

Department/Agency Department of National Defence. Surgeon General Branch.
Title Surgeon General report on mefloquine
Publication Type Monograph
Language [English]
Other Language Editions [French]
Format Electronic
Electronic Document

Archived Content

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact the authoring department to request a format other than those available.

We invite you to consult the Frequently Asked Questions page for additional information regarding the Archived Content notice.

Having trouble opening this document?

Note: The URLs contained in this/these document(s) may no longer be functional
Note Issued also in French under title: Rapport du médecin général sur la méfloquine. Cover title.
Date [2017]
Number of Pages 66 p. :
Catalogue Number
  • D2-526/2017E-PDF
Subject Terms Military personnel, Drugs, Health impact